Navigate Effortlessly with Marketing Browser

GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients

by nayab | Mar 10, 2025 | Google Finance News | 0 comments

GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients

GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients

Source: News-Medical.Net

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 diabetes patients, especially compared to insulin.
The study also highlights GLP-1RAs’ potential as a cancer-protective treatment, independent of glucose control.

Could a diabetes drug slash your cancer risk? New research shows GLP-1 receptor agonists may protect patients with type 2 diabetes from deadly blood cancers—beyond just managing blood sugar.
Glucagon-like peptide 1 (GLP-1, 7-36) molecule — a potent a… [4886 chars]

Read more

Written By Alison Rabbecca

undefined

Related Posts

Submit a Comment

Your email address will not be published. Required fields are marked *

https://postback.hilltopads.com/close/?token={{ctoken}}&advertiserId=292942